You need to be logged in to view this video
Three Unique and Differentiated ETFs for Today's Market
Released on Wednesday, June 22, 2022•ETFs
Today's market calls for differentiated and idiosyncratic strategies and Kelly ETFs will present three ETFs to help investors potentially diversify their portfolios. One ETF is a biotechnology strategy that is seeking to revolutionize healthcare focusing on CRISPR, one is a US-focused strategy to potentially capitalize on inflation, and the final ETF is set to benefit from the reopening of the economy as we go from pandemic to endemic.
Kevin Kelly is responsible for product design, structuring, managing retail and institutional investment research, and capital markets. He also serves as the CEO of Kelly Benchmark Indexes, the index provider, and sponsor of the SRVR and INDS ETFs. In September 2014, Nasdaq named Mr. Kelly an ETF Insider, and he is a recognized leader in ETF design, distribution and growth with his extensive track record of launching multi-billion-dollar ETFs. Mr. Kelly's thought leadership on markets, derivatives, e-commerce, and technology can be found weekly in top media outlets.
Filter By Category
Filter By Keywords